Why is the MenB vaccine not routinely offered to all young adults on the NHS?

The JCVI currently advises on vaccination schedules, with the MenB vaccine primarily offered to infants, leaving a gap for young adults.

What are the long-term consequences for Meningitis survivors?

Survivors can face severe lifelong issues, including amputation, deafness, epilepsy, and learning difficulties.

How quickly can Meningitis B be fatal?

Meningitis B is a rapid illness and can be fatal for up to one in 10 affected individuals, sometimes within 24 hours.

Home / Health / Meningitis B: Families Demand Action for Young Adults

Meningitis B: Families Demand Action for Young Adults

2 Dec

•

Summary

Advocates push for MenB vaccine availability for young adults on NHS.
One in four Meningitis survivors face lifelong health complications.
Meningitis B can be fatal within 24 hours if not treated promptly.

Meningitis B: Families Demand Action for Young Adults

Grief has fueled a powerful advocacy for enhanced Meningitis B awareness and vaccine accessibility. Following a young adult's death from the disease, her family is determined to prevent further tragedies, emphasizing that her passing should not be in vain. They champion the provision of the MenB vaccine on the NHS for young adults, a group currently not routinely covered.

This push comes amid stark statistics: one in four Meningitis survivors endure permanent health problems, while the illness itself can prove fatal within a mere 24 hours. Health organizations and student unions are amplifying calls for preventative measures, stressing that early detection and vaccination are crucial. Universities are also urged to consider offering the vaccine to their students, removing cost barriers to life-saving immunizations.